An Analysis of NICE ‘Restricted’ (or ‘Optimized’) Decisions

Article examins the attempt to develop a robust and defensible means of measuring and describing the degree of patient access in mixed NICE decisions.(Source: Pharmacoeconomics, O’Neill et al)